Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
27.8M
-
Shares change
-
+1.1M
-
Total reported value, excl. options
-
$891M
-
Value change
-
+$36.3M
-
Put/Call ratio
-
0.57
-
Number of buys
-
83
-
Number of sells
-
-51
-
Price
-
$32.11
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q3 2015
179 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2015.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.8M shares
of 106M outstanding shares and own 26.28% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (2.78M shares), VANGUARD GROUP INC (2.57M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (2.13M shares), FMR LLC (2.08M shares), BlackRock Fund Advisors (1.57M shares), STATE STREET CORP (1.35M shares), D. E. Shaw & Co., Inc. (1.06M shares), BlackRock Institutional Trust Company, N.A. (936K shares), CITADEL ADVISORS LLC (918K shares), and Point72 Asset Management, L.P. (910K shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.